Literature DB >> 9176150

Tension response of the cardiotonic agent (+)-EMD-57033 at the single cell level.

C Vannier1, V Lakomkine, G Vassort.   

Abstract

The effects of the Ca sensitizer (+)-EMD-57033 were tested on single chemically skinned cells isolated from rat ventricle. The present study demonstrates that (+)-EMD-57033 (10 microM) increased maximal force by 20% (at pCa 4.5) and myofilament Ca sensitivity by 0.2 pCa unit. However, the force-length dependency was not affected by the addition of (+)-EMD-57033, since similar Ca-sensitizing effects occurred at different sarcomere lengths. Consequently, the Ca-sensitizing effect of the drug and of the sarcomere length might be additive. Cross-bridge kinetics were also investigated in the presence of the thiadiazinone derivative. (+)-EMD-57033 induced marked increases in the rate of tension redevelopment (ktr) after brief slack release/restretch, particularly at low Ca concentrations. These results suggest that the Ca-sensitizing effects of (+)-EMD-57033 are due, at least in part, to an increased number of attached cross bridges during one cyclo. This observation, together with the increase in peak force, is discussed in relation to the reduction in energy cost induced by such Ca-sensitizing agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176150     DOI: 10.1152/ajpcell.1997.272.5.C1586

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  EMD 57033 partially reverses ventilator-induced diaphragm muscle fibre calcium desensitisation.

Authors:  Julien Ochala; Peter J Radell; Lars I Eriksson; Lars Larsson
Journal:  Pflugers Arch       Date:  2009-10-02       Impact factor: 3.657

2.  The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.

Authors:  L Nagy; Á Kovács; B Bódi; E T Pásztor; G Á Fülöp; A Tóth; I Édes; Z Papp
Journal:  Br J Pharmacol       Date:  2015-08-04       Impact factor: 8.739

3.  Defective regulation of contractile function in muscle fibres carrying an E41K beta-tropomyosin mutation.

Authors:  Julien Ochala; Meishan Li; Monica Ohlsson; Anders Oldfors; Lars Larsson
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

4.  SR33805, a Ca2+ antagonist with length-dependent Ca2+ -sensitizing properties in cardiac myocytes.

Authors:  Olivier Cazorla; Alain Lacampagne; Jeremy Fauconnier; Guy Vassort
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

5.  Effects of Ca2+ -sensitizers in permeabilized cardiac myocytes from donor and end-stage failing human hearts.

Authors:  Z Papp; J Van Der Velden; A Borbély; I Edes; G J M Stienen
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.